The UK government recently decided to extend the interval between the first dose of the Pfizer BioNTech and AstraZeneca COVID-19 vaccines from 3 weeks to 12 weeks to maximise the number of people receiving the initial dose, despite the trials only providing vaccine efficacy data based on a schedule of 21 days between doses. This editorial discusses whether there is evidence to support this policy change.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.12968/hmed.2021.0047 | DOI Listing |
Publication Analysis
Top Keywords
covid-19 vaccines
8
vaccines happened
4
happened evidence-based
4
evidence-based medicine?
4
medicine? government
4
government decided
4
decided extend
4
extend interval
4
interval dose
4
dose pfizer
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!